Several phosphorylations in the proline rich regionof tau have been quantified in CSF using commercially available invitro diagnostics (IVD) immunoassay kits discriminating AD patients,mild cognitive impairment (MCI), and healthy subjects. The gene discussed is MAPT; the disease is Alzheimer disease.